byiShook Opinion
Feb 5, 2025 - 10:05
GSK delivered a mixed fourth-quarter report Wednesday, but GSK stock surged on its long-term outlook for more than $50 billion in sales. The post GSK Surges 7% After Bumping Its 2031 Outlook To North Of $50 Billion appeared first on Investor's Business Daily.
GSK delivered a mixed fourth-quarter report Wednesday, but GSK stock surged on its long-term outlook for more than $50 billion in sales.
The post GSK Surges 7% After Bumping Its 2031 Outlook To North Of $50 Billion appeared first on Investor's Business Daily.